These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 33460830)

  • 1. Re: "High prevalence of heterotopic ossification in critically ill patients with severe COVID-19" by Stoira et al.
    de l'Escalopier N; Mathieu L; Duret C; Banzet S; Genêt F; Salga M
    Clin Microbiol Infect; 2021 Jul; 27(7):1051-1052. PubMed ID: 33460830
    [No Abstract]   [Full Text] [Related]  

  • 2. 'High prevalence of heterotopic ossification in critically ill patients with severe COVID-19' - Author's reply.
    Stoira E; Chiesa AF; Elzi L
    Clin Microbiol Infect; 2021 Jul; 27(7):1053. PubMed ID: 33607253
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of heterotopic ossification in critically ill patients with severe COVID-19.
    Stoira E; Elzi L; Puligheddu C; Garibaldi R; Voinea C; Chiesa AF;
    Clin Microbiol Infect; 2021 Jul; 27(7):1049-1050. PubMed ID: 33460831
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heterotopic ossifications after hospitalisation in intensive care for SARS-CoV-2 pneumopathy].
    Grosjean D; Dekoster M; Beaudart C; Kaux JF
    Rev Med Liege; 2022 Jan; 77(1):13-17. PubMed ID: 35029335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: 'Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review' by Serafim et al.
    Lipes J; Yang SS
    Clin Microbiol Infect; 2021 Jun; 27(6):938-939. PubMed ID: 33484842
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterotopic ossification in COVID-19: A series of 4 cases.
    Meyer C; Haustrate MA; Nisolle JF; Deltombe T
    Ann Phys Rehabil Med; 2020 Nov; 63(6):565-567. PubMed ID: 33115691
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915-918.
    Gando A; Alexay S; Galán Núñez JP; Cano LN; Diez RA; Costa LA
    J Med Virol; 2021 May; 93(5):2626-2627. PubMed ID: 33590886
    [No Abstract]   [Full Text] [Related]  

  • 8. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.
    Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X
    Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Orthopedic Manifestations of COVID-19: Heterotopic Ossification and Digital Necrosis.
    Liu J; Luther L; Dwivedi S; Evans AR
    R I Med J (2013); 2022 Sep; 105(7):31-35. PubMed ID: 35930488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    Yan Y; Jiang X; Fu J; Huang J; Qiu Y; Ding D; Ge L; Zhang H; Huang L; Lu X; Hu Q
    J Infect; 2021 Apr; 82(4):84-123. PubMed ID: 33188798
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Course and Outcome of Critically Ill Clinical COVID-19 Pneumonia or Severe Acute Respiratory Illness.
    Rao CM; Jena SK; Patnaik S; Singh N; Gupta S; Priyadarshini S; Pradhan S; Das S
    J Assoc Physicians India; 2021 May; 69(5):42-49. PubMed ID: 34189886
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of critically ill COVID-19 patients: challenges and affordable solutions.
    Caresia CE
    Pan Afr Med J; 2021; 38():270. PubMed ID: 34122697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Peters J; Köhler HC; Oltmanns K; Besselmann M; Zwaan M; Gutcke A; Rüttermann M
    Rehabilitation (Stuttg); 2021 Aug; 60(4):231-234. PubMed ID: 34428803
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe neurological complications in critically ill COVID-19 patients.
    Notz Q; Lotz C; Herrmann J; Vogt M; Schlesinger T; Kredel M; Muellges W; Weismann D; Westermaier T; Meybohm P; Kranke P
    J Neurol; 2021 May; 268(5):1576-1579. PubMed ID: 32797297
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection in Blood of Critically Ill Patients.
    Buetti N; Patrier J; Le Hingrat Q; Loiodice A; Bouadma L; Visseaux B; Timsit JF
    Clin Infect Dis; 2021 May; 72(10):e690-e691. PubMed ID: 32875309
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best practice statements and recommendations for caring for critically ill patients with COVID-19.
    Dugar SP; Vallabhajosyula S
    Ann Intern Med; 2020 Jun; 172(12):JC62. PubMed ID: 32539521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to Wengenmayer
    Monnier A; Falcoz PE; Helms J; Meziani F
    Am J Respir Crit Care Med; 2020 Nov; 202(10):1479-1480. PubMed ID: 32795240
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    Rosas IO; Raby B; Tsai L
    N Engl J Med; 2021 Sep; 385(12):1149. PubMed ID: 34407336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.